News New paediatric use for Allergan's biosimilar-threatened Boto... Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity.
News FDA approves Herceptin biosimilar as US patent expires The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.
News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Collaborating to fight NASH Eric Hughes, Global Development Unit head at Novartis for Immunology, Hepatology & Dermatology, believes that collaboration is going to be key to finally finding a treatment for non
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
